Edition:
United States

Getinge AB (GETIb.ST)

GETIb.ST on Stockholm Stock Exchange

120.40SEK
15 Dec 2017
Change (% chg)

-0.40kr (-0.33%)
Prev Close
120.80kr
Open
120.80kr
Day's High
121.20kr
Day's Low
119.80kr
Volume
909,298
Avg. Vol
1,119,122
52-wk High
182.06kr
52-wk Low
118.50kr

Chart for

About

Getinge AB is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas: The Medical Systems business area offers... (more)

Overall

Beta: 1.24
Market Cap(Mil.): kr30,701.61
Shares Outstanding(Mil.): 254.15
Dividend: 1.97
Yield (%): 1.63

Financials

  Industry Sector
P/E (TTM): -- 58.86 16.04
EPS (TTM): -- -- --
ROI: -- 13.32 35.70
ROE: -- 19.82 15.40

UPDATE 1-Getinge sets new financial targets ahead of Arjo listing

Nov 10 Swedish medical technology firm Getinge on Friday announced new financial targets following the proposed distribution and separate listing of its patient & post-acute care business, now called Arjo.

Nov 10 2017

BRIEF-Getinge sets new financial targets after distribution of Arjo

* Revised strategy, new financial targets and restated financial information for Getinge (excluding Arjo)

Nov 10 2017

REFILE-UPDATE 2-Getinge hopes to spin off PPAC division this year after Q3 profit dives

STOCKHOLM, Oct 18 Medical technology firm Getinge reported on Wednesday quarterly core profits below expectations, sending its shares down, and said it now hoped to spin off and list its smallest division by year-end.

Oct 18 2017

BRIEF-Getinge Q3 core profit lags expectations, targets PPAC listing by year-end ​

* Q3 ‍order intake increased by 2.2% to sek 7,334 m (7,176). Order intake increased organically by 4.7%.​

Oct 18 2017

BRIEF-Getinge's rights issue fully subscribed

* The preliminary result of Getinge rights issue shows that over 33.7 million shares, corresponding to approximately 99.2 percent of the shares in the offer, were subscribed for with subscription rights

Sep 18 2017

BRIEF-Getinge resolves on fully guaranteed 4 bln SEK rights issue

* says today, the Board of Directors of Getinge AB, with authorization from the Extraordinary General Meeting on August 15, 2017, has resolved on a rights issue of MSEK 4,324 with the purpose to strengthen the group’s balance sheet by reducing leverage and thereby providing improved operational flexibility

Aug 18 2017

BRIEF-Getinge to cooperate with Brazilian authorities on cartel probe

* Getinge says to cooperate with Brazilian authorities on local ongoing investigations

Aug 03 2017

UPDATE 1-Getinge Q2 core profit lags forecast, makes new provision over Hechingen

July 17 Swedish medical technology firm Getinge posted second-quarter core profits and order intake below expectations on Monday and said it had taken a new provision for quality related work at one of its plants.

Jul 17 2017

RPT-BRIEF-Getinge Q2 core profit lags forecast, makes new provision over Hechingen

* Q2 EBITA before acquisition, restructuring and integration costs increased 9.6% to SEK 864 m (788).

Jul 17 2017

BRIEF-Getinge Q2 core profit lags forecast, makes new provision over Hechingen

* Q2 EBITA before acquisition, restructuring and integration costs increased 9.6% to SEK 864 m (788).

Jul 17 2017

Earnings vs. Estimates